Cargando…
Histology-Agnostic Drugs: A Paradigm Shift—A Narrative Review
Cancer diagnosis and therapeutics have been traditionally based on pathologic classification at the organ of origin. The availability of an unprecedented amount of clinical and biologic data provides a unique window of opportunity for the development of new drugs. What was once treated as a homogene...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070286/ https://www.ncbi.nlm.nih.gov/pubmed/36418841 http://dx.doi.org/10.1007/s12325-022-02362-4 |